A large number of studies conducted in the APP/PS1 transgenic mice, which recapitulates most features of AD pathology, has consistently concluded that β-amyloid deposition, microglial NLRP3 activation and IL-1β release is an early feature of AD progression [124]. The gene discussed is IL1B; the disease is Alzheimer disease.